Indications for allogeneic stem cell transplantation in patients with AML

被引：0
|
作者：
Passweg, J. [1 ]
机构：
[1] Univ Spital Basel, Hamatol, Basel, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V747
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [21] Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
    Hobbs, Gabriela Soriano
    Perales, Miguel-Angel
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (03): : 488 - 503
  • [22] Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission
    Versluis, Jurjen
    Cornelissen, Jan J.
    HEMASPHERE, 2018, 2 : 162 - 164
  • [23] HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
    Roerden, Malte
    Nelde, Annika
    Heitmann, Jonas S.
    Klein, Reinhild
    Rammensee, Hans-Georg
    Bethge, Wolfgang A.
    Walz, Juliane S.
    CANCERS, 2020, 12 (07) : 1 - 10
  • [24] Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation
    Nachbaur, D.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 104 - 107
  • [25] Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation
    David Nachbaur
    memo - Magazine of European Medical Oncology, 2009, 2 (2) : 104 - 107
  • [26] Paediatric allogeneic and autologous stem cell transplantation in AML: Istanbul experience
    Anak, S
    Bilgen, H
    Can, E
    Ozgenc, S
    Gedikoglu, G
    BONE MARROW TRANSPLANTATION, 2002, 30 : S58 - S58
  • [27] Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS
    Kennedy, GA
    Butler, J
    Durrant, S
    Hill, GR
    Western, R
    Morton, J
    BLOOD, 2005, 106 (11) : 438B - 439B
  • [28] Impact of comorbidity on the outcome of allogeneic hematopoietic stem cell transplantation in AML/MDS patients.
    Shahjahan, M
    Alamo, J
    Delima, M
    Khouri, I
    Gajewski, J
    Andersson, BS
    Champlin, RE
    Giralt, S
    BLOOD, 2003, 102 (11) : 708A - 708A
  • [29] Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (≥60 years)
    Pohlen, M.
    Groth, C.
    Sauer, T.
    Goerlich, D.
    Mesters, R.
    Schliemann, C.
    Lenz, G.
    Mueller-Tidow, C.
    Buechner, T.
    Berdel, W. E.
    Stelljes, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1441 - 1448
  • [30] The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients
    Chen, Wen-Chun
    Gau, Jyh-Pyng, Sr.
    Hsiao, Liang-Tsai
    Liu, Chia-Jen
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Liu, Jin-Hwang
    Chiou, Tzeon-Jye
    BLOOD, 2019, 134
12345